The importance of E-cadherin loss in cancer progression has been clearly demonstrated in mouse models in vivo, where the artificial maintenance of E-cadherin expression in a pancreas islet cell tumor model caused tumors to arrest at the adenoma stage, while inactivation of E-cadherin caused tumors to progress from adenomas to carcinoma [17]. This evidence concerns the gene CDH1 and cancer.